An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines Agency (EMA) considerate it as an alternative than the current lower ...

The FDA recently granted marketing authorization for the TriVerity Test System — a new molecular diagnostic test developed by Inflammatix. This first-of-its-kind test provides a comprehensive ...

Ways workplaces and insurance companies have begun to support menopausal women, according to Jenifer Allbright, director of G&A Beneficial.